Amplification of c- erb B-2 and Aggressive Human Breast Tumors?-Reference-Cited by-同舟云学术

Amplification of c- erb B-2 and Aggressive Human Breast Tumors?

Published:1988-06-24 Issue:4860 Volume:240 Page:1795-1798
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Ali Iqbal Unnisa¹,Campbell Gregory²,Lidereau Rosette³,Callahan Robert⁴

Affiliation:

1. Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, MD 20892.

2. Laboratory of Statistical and Mathematical Methodology, Division of Computer Research and Technology, National Institutes of Health, Bethesda, MD 20892.

3. Centre René Huguenin, 92211 St. Cloud, France.

4. Laboratory of Tumor Immunology and Biology, National Institutes of Health.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference15 articles.

1. Ali, I. U., Oncogene Research 3: 139 (1988).

2. Reduction to Homozygosity of Genes on Chromosome 11 in Human Breast Neoplasia

3. CLARK, G.M., PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER, NEW ENGLAND JOURNAL OF MEDICINE 309: 1343 (1983).

4. COX, D. R., JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY 34: 187 (1972).

5. Escot, C., Proceedings of the National Academy of Sciences of the United States of America 83: 4834 (1986).

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer;JNCI: Journal of the National Cancer Institute;2023-05-11

2. HER2-driven breast cancer suppression by the JNK signaling pathway;Proceedings of the National Academy of Sciences;2023-01-19

3. Recent Progress in Detection of Breast Cancer Biomarkers by Clinical and Imprinting Polymer-Based Sensors;Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications;2022

4. Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for Head and Neck Squamous Cell Carcinoma;Cell Transplantation;2020-01-01

5. Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines;JAMA Oncology;2019-03-01